 NEW YORK, Nov. 24, 2020 GLOBE NEWSWIRE -- BeyondSpring the Company or BeyondSpring NASDAQ: BYSI, a global biopharmaceutical company focused on the development of innovative cancer therapies, today announced a poster presentation about the PROTECTIVE-2 Trial ClinicalTrials.gov ID: NCT03294577 at the 62nd American Society of Hematology ASH Annual Meeting being held virtually December 5-8, 2020. The Company will also present three posters about the PROTECTIVE-1 Trial and PROTECTIVE-2 Trial at the San Antonio Breast Cancer Symposium SABCS being held virtually December 8-11, 2020. 